Stock TARA PROTARA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Protara Therapeutics, Inc.

Equities

TARA

US74365U1079

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
2.26 USD -6.22% Intraday chart for Protara Therapeutics, Inc. -12.06% +20.53%
05-02 Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-30 Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROTARA THERAPEUTICS, INC. Stock Protara Therapeutics, Inc.
 46.53M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 114B
ARGENX SE Stock argenx SE
 23.61B -
BIONTECH SE Stock BioNTech SE
 20.43B -
GENMAB A/S Stock Genmab A/S
 16.55B
  1. Stock Market
  2. Equities
  3. TARA Stock
  4. Charts Protara Therapeutics, Inc.
  5. Sector Chart